Lymphoma

Understanding treatment for lymphoma and how it is delivered

Last modified: March 9, 2022

What are the treatment options for lymphoma? Treatment options

The primary treatment options for lymphoma include chemotherapy, radiation therapy, bone marrow transplants (sometimes referred to as stem cell transplants), targeted therapies and monoclonal antibodies (immunotherapy). The type of treatment you receive will depend on a number of different considerations, such as the sub-type of lymphoma you have, its stage, your overall health and your treatment preferences. This page aims to give you a comprehensive overview of how lymphoma treatment works.

Types of lymphoma treatmentTypes of treatment

Chemotherapy for lymphomaChemotherapy

Chemotherapy uses a range of drugs to both kill and slow the growth of lymphoma cells. Typically, chemotherapy is the primary treatment for aggressive or advanced forms of lymphoma. In certain circumstances, chemotherapy drugs may be used in combination with other treatment methods such as antibody therapy, steroid therapy or radiation therapy.

Learn more about chemotherapy and how it is delivered.

Radiation therapy for lymphomaRadiation therapy

Patients who receive radiation therapy for lymphoma will commonly receive external beam radiation therapy (EBRT).

Radiation therapy may be used to treat early-stage lymphomas (stage I or II). Radiation therapy and chemotherapy may be used together in a treatment often referred to as chemo-radiation.

Targeted therapy for lymphoma Targeted therapies

Targeted therapies use specialised drugs to destroy specific proteins in lymphoma cells, while aiming leaving healthy cells intact. These drugs aim to stop lymphoma cells from repairing themselves when they get damaged.

Immunotherapy for lymphoma Immunotherapy

Immunotherapy treatment harnesses your own immune system to destroy and slow the growth of lymphoma cells.

Immunotherapy drugs may be combined with chemotherapy drugs, targeted therapies or used alone to treat lymphoma.

Monoclonal antibody drugs

Most immunotherapy drugs that are used to treat lymphoma are monoclonal antibodies, with the most common drugs (Rituximab and Obinutuzumab) being monoclonal antibodies directed against a molecule called CD20 which is present on the cell surface of many B-cell non-Hodgkin lymphomas.

Bone marrow transplant for lymphoma Bone marrow transplant

Bone marrow transplants, which are also referred to as stem cell transplants, replace a patient’s bone marrow with healthy stem cells that help stimulate the development of new, healthy bone marrow after the patient first receives high doses of chemotherapy, generally delivered intravenously, before the healthy stem cells are transplanted.

Bone marrow transplants are generally reserved for relapsed lymphoma.

Types of bone marrow transplants

There are two types of bone marrow transplants that you may receive for lymphoma:

Allogenic transplants

This refers to bone marrow (stem cells) given by a donor, often a relative or sometimes a HLA matched unrelated donor.

Autologous transplants

This is where your own stem cells are collected, then frozen (cryopreserved) and stored. Following the high dose chemotherapy these stem cells (ie. Your own stem cells) are then transfused into your bloodstream.

Treatment by stage of lymphomaTreatment by stage

When you are diagnosed with lymphoma, your haematologist will develop your treatment plan as part of a multidisciplinary team based on the type of lymphoma you have and its stage.

You can find common treatment options for both types of lymphoma by stage below.

Hodgkin lymphomaHodgkin lymphoma

  • Early stage disease (Ann Arbor Stages I and II)

    Early-stage Hodgkin lymphomas are typically treated, with two to four cycles of chemotherapy followed by radiation therapy.

  • Advanced stage disease (Ann Arbor Stages III and IV)

    Treatment for stage IV Hodgkin usually involves six cycles of chemotherapy, occasionally followed by radiation therapy.

Non-Hodgkin lymphomaNon-Hodgkin lymphoma

  • Early stage disease (Ann Arbor Stages I and II)

    Low grade, early-stage non-Hodgkin lymphoma is generally treated with radiation therapy although in some instances immunochemotherapy can either be given pre-radiation therapy (ie. Combined modality therapy) or instead of radiation therapy. For high grade, early-stage non-Hodgkin lymphoma  (also known as limited stage high-grade NHL), your doctor will generally recommend immuno-chemotherapy +/- radiation therapy directed at the affected lymph nodes.

  • Advanced stage disease (Ann Arbor Stages III and IV)

    Low grade, advanced-stage non-Hodgkin lymphoma can be managed with either: watch and wait, immunotherapy or immuno-chemotherapy. Stage III and IV (advanced stage) high-grade non-Hodgkin lymphoma is primarily treated with intensive immuno-chemotherapy for six to eight cycles of therapy using a combination of chemotherapy drugs and in many cases immunotherapy. Your doctor may also recommend a bone marrow transplant following your course of primary immuno-chemotherapy, although bone marrow transplants are often reserved for relapsed disease.

ReferencesReferences

For a full list of references, click here.
  1. American Cancer Society. (2018, August 1). Targeted therapy drugs for Non-Hodgkin Lymphoma. American Cancer Society. Retrieved March 7, 2022, from https://www.cancer.org/cancer/non-hodgkin-lymphoma/treating/targeted-therapy.html
  2. Cancer Council. (2019, November). Non-Hodgkin lymphoma: Causes, symptoms & treatments. Cancer Council. Retrieved March 7, 2022, from http://www.cancer.org.au/cancer-information/types-of-cancer/non-hodgkin-lymphoma
  3. Cancer Council. (2019, May). Hodgkin lymphoma: Causes, symptoms & treatments. Cancer Council. Retrieved March 7, 2022, from http://www.cancer.org.au/cancer-information/types-of-cancer/hodgkin-lymphoma
  4. Lymphoma Research Foundation. (2021, September 4). Treatment options for Lymphoma. Lymphoma Research Foundation. Retrieved March 7, 2022, from https://lymphoma.org/aboutlymphoma/treatments/
  5. American Cancer Society. (2018, August 1). Immunotherapy for Non-Hodgkin Lymphoma. American Cancer Society. Retrieved March 7, 2022, from http://www.cancer.org/cancer/non-hodgkin-lymphoma/treating/immunotherapy.html
  6. Cancer Research UK. (2020, September 22). Stages of hodgkin lymphoma. Hodgkin Lymphoma | Cancer Research UK. Retrieved March 7, 2022, from http://www.cancerresearchuk.org/about-cancer/hodgkin-lymphoma/stages
  7. Cancer Research UK. (2020, December 16). Treatment for low grade non-Hodgkin Lymphoma. Non-Hodgkin lymphoma | Cancer Research UK. Retrieved March 7, 2022, from http://www.cancerresearchuk.org/about-cancer/non-hodgkin-lymphoma/treatment/low-grade
  8. Cancer Research UK. (2020, December 18). Treatment for high grade non-Hodgkin Lymphoma. Non-Hodgkin lymphoma | Cancer Research UK. Retrieved March 7, 2022, from https://www.cancerresearchuk.org/about-cancer/non-hodgkin-lymphoma/treatment/high-grade
  9. Cancer Institute of NSW. EviQ. Lymphoma. Retrieved 24 February 2022 from https://www.eviq.org.au/haematology-and-bmt/lymphoma
  10. Lymphoma Australia. Immunotherapy Treatment. Retrieved 24 February 2022 from https://www.lymphoma.org.au/about-lymphoma/treatments/immunotherapy/antibody-therapy/
View all

Search

Make An Appointment